Trevena Inc. appointed Mark Demitrack as senior vice president and chief medical officer.
Before joining the Chesterbrook, Pa.-based biopharmaceutical company, Demitrack was vice president of clinical strategy at Roivant Sciences Inc.
Trevena develops therapies based on breakthrough science to treat serious medical conditions.
